Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples